Abstract
Endotoxemia is a serious and cumbersome illness, especially for immunocompromised patients who are susceptible to drug-resistant enteric bacteria. In an attempt to explore immunoprophylactic measures applicable to humans, protective efficacies of antibodies to lipopolysaccharide (LPS) have been extensively studied. Thus antibodies to heterologous R core (Braude et al. 1977; Davis et al. 1978; Marks et al. 1982; Ziegler et al.1982) as well as those to homologous O polysaccharides (Freedman 1959; Dunn et al. 1985) are now believed to be able, at least to some extent, to prevent animals and humans from developing endotoxemia. However, it is not yet clear how antibodies to O and R resions located at different spacings from lipid A can equally neutralize the toxic activities of LPS, whereas antibodies to the toxic lipid A moiety itself often fail to do so. In this study, we have prepared mouse monoclonal antibodies (mAbs) of the IgG class to these three regions of LPS and compared their effects on the toxic activities of LPS in vivo and in vitro to look into the mechanism for neutralization by these antibodies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aggarwell BB, Kohr WJ, Harkins RN (1985) Human tumor necrosis factor. Production, purification and characterization. J Biol Chem 260: 2345–2354
Braude AI, Douglas H, Ziegler EJ (1977) Antibody to cell wall glycolipid of gram-negative bacteria: induction of immunity to bacteremia and endotoxemia. J Infect Dis S136: S167–173
Davis CE, Ziegler EJ, Arnold KF (1978) Neutralization of meningococcal endotoxin by antibody to core glycolipid. J Exp Med 147: 57–67
Dunn DL, Bogard WC, Cerra FB (1985) Enhanced survival during murine gram-negative bacterial sepsis by use of a murine monoclonal antibody. Arch Surg 120: 50–53
Freedman HH (1959) Passive transfer of protection against lethality of homologous and heterologous endotoxins. Proc Soc Exp Biol Med 102: 504–506
Galanos C, Lüderitz O, Westphal O (1971) Preparation and properties of antisera against the lipid A component of bacterial lipopolysaccharides. Eur J Biochem 24: 110–122
Marks MI, Ziegler EJ, Braude AI (1982) Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopoly saccharide. J Clin Invest 69: 742–749
Mizel SB, Oppenheim JJ, Rosenstreich DL (1978) Characterization of lymphocyte activating factor (LAF) produced by a macrophage cell line. P388D1. J Immunol 120: 1497–1503
Oi VT, Herzenberg LA (1980) Immunoglobulin-producing hybrid cell lines. In: Mishell BB (ed) Selected methods in cellular immunology. Freeman, San Francisco, pp 351–372
Radvany R, Neale NL, Novotny A (1966) Relation of structure to function in bacterial O-antigens. VI. Neutralization of endotoxic O antigens by homologous O-antibody. Ann NY Acad Sci 133: 763–786
Ziegler EJ, Douglas H, Blaude AI (1982) Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307: 1225–1230
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
Sagawa, T., Abe, Y., Kimura, S., Hitsumoto, Y., Utsumi, S. (1989). Mechanisms of Neutralization of Endotoxin by Monoclonal IgG Antibodies to Lipopolysaccharide. In: Faist, E., Ninnemann, J.L., Green, D.R. (eds) Immune Consequences of Trauma, Shock, and Sepsis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73468-7_61
Download citation
DOI: https://doi.org/10.1007/978-3-642-73468-7_61
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73470-0
Online ISBN: 978-3-642-73468-7
eBook Packages: Springer Book Archive